ConductScience.org, home

Paper22166408

Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia.

Iravani MM and 2 others. Parkinsonism Relat Disord, 2012. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia. Papers, record 22166408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22166408

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia.
PubMed
Journal
Parkinsonism Relat Disord
PubMed
Year
2012
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.15
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iravani MMM M
2McCreary ACA C
3Jenner PP

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Corpus StriatumMajor topic
Dyskinesia, Drug-InducedMajor topic
LevodopaMajor topic
Neuronal PlasticityMajor topic
Parkinson DiseaseMajor topic
Animals
Antiparkinson Agents
Humans

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G-0804Parkinson's UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
40244021The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson's Disease.Int J Mol Sci2025https://conductscience.org/library/papers/40244021PubMed
39456033Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits.Cell Biosci2024https://conductscience.org/library/papers/39456033PubMed
38664012Differential Activation States of Direct Pathway Striatal Output Neurons during l-DOPA-Induced Dyskinesia Development.J Neurosci2024https://conductscience.org/library/papers/38664012PubMed
37568874Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson's Disease in the First 6 Years of Levodopa Treatment.Diagnostics (Basel)2023https://conductscience.org/library/papers/37568874PubMed
36740977iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation.EMBO Mol Med2023https://conductscience.org/library/papers/36740977PubMed
35903042Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single-center long-term follow-up study.Acta Neurol Scand2022https://conductscience.org/library/papers/35903042PubMed
34776935Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry.Front Aging Neurosci2021https://conductscience.org/library/papers/34776935PubMed
34117268Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study.NPJ Parkinsons Dis2021https://conductscience.org/library/papers/34117268PubMed
33808538Dopamine D3 Receptor Plasticity in Parkinson's Disease and L-DOPA-Induced Dyskinesia.Biomedicines2021https://conductscience.org/library/papers/33808538PubMed
33023066Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.Int J Mol Sci2020https://conductscience.org/library/papers/33023066PubMed
32488298Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications.J Neurol2020https://conductscience.org/library/papers/32488298PubMed
31335998Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease.Mov Disord2019https://conductscience.org/library/papers/31335998PubMed
30137517Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.Nicotine Tob Res2019https://conductscience.org/library/papers/30137517PubMed
29125979Synaptic plasticity may underlie l-DOPA induced dyskinesia.Curr Opin Neurobiol2018https://conductscience.org/library/papers/29125979PubMed
29075830Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.Eur J Nucl Med Mol Imaging2018https://conductscience.org/library/papers/29075830PubMed
28904447Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management.Ann Indian Acad Neurol2017https://conductscience.org/library/papers/28904447PubMed
26941635On the Complexity of Brain Disorders: A Symptom-Based Approach.Front Comput Neurosci2016https://conductscience.org/library/papers/26941635PubMed
26921469Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias.Neurobiol Dis2016https://conductscience.org/library/papers/26921469PubMed
26686676Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.Metab Brain Dis2016https://conductscience.org/library/papers/26686676PubMed
26573698α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.Mov Disord2015https://conductscience.org/library/papers/26573698PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22166408

GET https://conductscience.org/api/papers/v1/22166408/cited_by?page=2